Peter M. Hecht 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-28 9:47 pm Purchase | 2025-03-25 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 1,028,086 27.900% | 187,187 (+22.26%) | Filing |
| 2023-12-05 4:00 pm Purchase | 2023-11-30 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 840,899 26.900% | 322,435 (+62.19%) | Filing |
| 2023-05-23 4:00 pm Purchase | 2023-05-19 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 518,464 19.990% | 518,464 (New Position) | Filing |